<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Diffusion Pharmaceuticals &#187; Partners</title>
	<atom:link href="http://www.diffusionpharma.com/category/partners/feed" rel="self" type="application/rss+xml" />
	<link>http://www.diffusionpharma.com</link>
	<description></description>
	<lastBuildDate>Mon, 06 Feb 2012 14:39:17 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Diffusion Pharmaceuticals Announces Additional Funding from the Office of Naval Research (ONR) Bringing the Company’s Total Navy Funding to $2.6 Million</title>
		<link>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-announces-additional-funding-from-the-office-of-naval-research-onr-bringing-the-company%e2%80%99s-total-navy-funding-to-26-million</link>
		<comments>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-announces-additional-funding-from-the-office-of-naval-research-onr-bringing-the-company%e2%80%99s-total-navy-funding-to-26-million#comments</comments>
		<pubDate>Fri, 02 Feb 2007 14:44:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Funding]]></category>
		<category><![CDATA[Partners]]></category>
		<category><![CDATA[Progress]]></category>

		<guid isPermaLink="false">http://208.109.62.72/?p=75</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – February 2, 2007 – Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary approach to treat life-threatening diseases, today announced that it has received a $0.5 million grant (N00014-07-C-0424) from the Office of Naval Research (ONR). The funds will be used to support the transition of the company’s lead [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-announces-additional-funding-from-the-office-of-naval-research-onr-bringing-the-company%e2%80%99s-total-navy-funding-to-26-million/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals LLC Announces Strategic Alliance to Develop New Cancer Therapies</title>
		<link>http://www.diffusionpharma.com/partners/diffusion-pharmaceuticals-llc-announces-strategic-alliance-to-develop-new-cancer-therapies</link>
		<comments>http://www.diffusionpharma.com/partners/diffusion-pharmaceuticals-llc-announces-strategic-alliance-to-develop-new-cancer-therapies#comments</comments>
		<pubDate>Tue, 01 Mar 2005 14:53:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Partners]]></category>

		<guid isPermaLink="false">http://208.109.62.72/?p=82</guid>
		<description><![CDATA[Charlottesville, VA — March 1, 2005 — Diffusion Pharmaceuticals LLC, a company that discovers and develops novel small-molecule therapeutics, today announced that it has reached an agreement with the New Approaches to Brain Tumor Therapy CNS Consortium (NABTT) for a comprehensive clinical trials program to test Diffusion’s lead drug candidate, trans sodium crocetinate (TSC), as [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/partners/diffusion-pharmaceuticals-llc-announces-strategic-alliance-to-develop-new-cancer-therapies/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals Announces $1 Million Grant and, Citing Growth, Two New Hires</title>
		<link>http://www.diffusionpharma.com/awards/diffusion-pharmaceuticals-announces-1-million-grant-and-citing-growth-two-new-hires</link>
		<comments>http://www.diffusionpharma.com/awards/diffusion-pharmaceuticals-announces-1-million-grant-and-citing-growth-two-new-hires#comments</comments>
		<pubDate>Tue, 07 Sep 2004 14:55:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Awards]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Partners]]></category>
		<category><![CDATA[Staff]]></category>

		<guid isPermaLink="false">http://208.109.62.72/?p=85</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA &#8212; Tuesday, September 7, 2004 &#8212; Diffusion Pharmaceuticals, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced it has been awarded a $1 million appropriation in the FY 2005 Defense Budget, which President Bush signed last month. These funds are allocated for studies to advance its lead compound, trans [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/awards/diffusion-pharmaceuticals-announces-1-million-grant-and-citing-growth-two-new-hires/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

